Case report demonstrates infliximab-induced resolution of progressive coronary aneurysms in a neonate with Kawasaki disease, highlighting the role of early escalated immunomodulatory therapy.
Kawasaki disease (KD) presents with medium vessel vasculitis. The condition is rare in newborns. We present a previously healthy 4-week-old baby with fever and evolving mucocutaneous involvement. Infectious workup was negative, but inflammatory markers (C-reactive protein, leucocytosis and thrombocytosis) progressively worsened. Serial echocardiography (initially normal) showed a small right coronary artery aneurysm (1.89 mm, z-score +2.77). Treatment was initiated with intravenous immunoglobulin (IVIG), aspirin and corticosteroids. Though clinical improvement was noted, repeat echocardiography demonstrated involvement of the left anterior descending artery (1.69 mm, z-score +2.65) and left circumflex artery (1.62 mm, z-score +2.72). Coronary artery disease progression occurred despite fever resolution with IVIG and steroids, prompting escalation to infliximab due to serial echocardiographic worsening. Subsequent follow-up showed regression and resolution of coronary dilation. This report emphasises the need for consideration of an alternative diagnosis if workup for sepsis-like illness does not reveal a clear pathogenic aetiology. Rapid and optimal escalation of therapy with immunomodulators plays a crucial role in halting progression and facilitating resolution of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: